Dialysis blood pressure mystery: could a simple blood test hold clues?

NCT ID NCT07438925

Ongoing Knowledge-focused Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is investigating whether a substance called copeptin, which is a stable marker of the hormone vasopressin, is linked to blood pressure changes that happen during hemodialysis. Researchers will measure copeptin levels in routine blood samples from 71 adults on chronic dialysis and compare them with blood pressure readings taken before, during, and after sessions. The goal is to better understand how the body regulates fluid and blood pressure during dialysis, which could eventually help improve patient care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand blood pressure swings during dialysis, potentially leading to improved monitoring or treatment strategies.
What could go wrong: This is a small, observational study (71 people) that only looks for a link, not a treatment. The results may not apply to all dialysis patients or lead to any direct changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes insipidus end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMODIALYSIS

Contacts and locations

Show contact details

Locations

CHRU de Nancy

Vandœuvre-lès-Nancy, 54500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.